Functional Roles of 3 0-Terminal Structures of Template RNA During

Total Page:16

File Type:pdf, Size:1020Kb

Functional Roles of 3 0-Terminal Structures of Template RNA During Nucleic Acids Research, 2005, Vol. 33, No. 6 1993–2002 doi:10.1093/nar/gki347 Functional roles of 30-terminal structures of template RNA during in vivo retrotransposition of non-LTR retrotransposon, R1Bm Tomohiro Anzai, Mizuko Osanai, Mitsuhiro Hamada and Haruhiko Fujiwara* Department of Integrated Biosciences, Graduate School of Frontier Sciences, University of Tokyo, Bioscience Building 501, Kashiwa, 277-8562, Japan Received as resubmission March 3, 2005; Revised March 9, 2005; Accepted March 21, 2005 ABSTRACT elements. LINEs have been identified in all major groups of eukaryotes, with the exception of the bdelloid rotifers (1). In R1Bm is a non-LTR retrotransposon found specific- humans, up to 21% of the genome is comprised of LINEs (2), ally within 28S rRNA genes of the silkworm. Different and the involvement of LINEs in the gene evolution and gen- from other non-LTR retrotransposons encoding ome reconstruction had been proposed (3–5). two open reading frames (ORFs), R1Bm structurally LINEs can be classified into two subtypes based on their lacks a poly (A) tract at its 30 end. To study how R1Bm structures and modes of retrotransposition (6). The early- initiates reverse transcription from the poly (A)-less branched subtype, such as R2 element specifically integrated template RNA, we established an in vivo retrotrans- in 28S rDNA of arthropods, comprises a single open reading position system using recombinant baculovirus, and frame (ORF) that encodes reverse transcriptase (RT) in the characterized retrotransposition activities of R1Bm. middle and a restriction enzyme-like endonuclease (EN) near Target-primed reverse transcription (TPRT) of R1Bm its C-terminal end (7,8). Biochemical analyses of R2Bm of the silkworm led to the current model for LINE retrotransposition. occurred from the cleavage site generated by endo- 0 0 R2Bm protein first recognizes the 3 UTR sequence of R2 nuclease (EN). The 147 bp of 3 -untranslated region RNA, and makes a specific nick on the target DNA by its 0 (3 UTR) was essential for efficient retrotransposition endonuclease (9,10). Then, the exposed 30 hydroxyl is utilized of R1Bm. Even using the complete R1Bm element, to initiate reverse transcription of the RNA template (11). however, reverse transcription started from various Thus, the processes of nicking, reverse transcription and integ- sites of the template RNA mostly with 50-UG-30 or ration are basically coupled, which are termed target-primed 50-UGU-30 at their 30 ends, which are presumably reverse transcription (TPRT). It is suggested that the rare base-paired with 30 end of the EN-digested 28S rDNA transcript of R2 element is provided by co-transcription target sequence, 50-AGTAGATAGGGACA-30. When with the 28S rDNA target (12,13), and an additional 28S the downstream sequence of 28S rDNA target was rRNA sequence downstream of the R2 sequence reduced added to the 30 end of R1 unit, reverse transcription the efficiency of the reaction, but increased the rate of accurate junctions seen in vivo (14). started exactly from the 30 end of 30UTR and retro- The recently-branched subtype of LINEs has two ORFs: transposition efficiency increased. These results ORF1 and ORF2. The ORF2 encodes catalytic domains 0 indicate that 3 -terminal structure of template RNA responsible for LINE retrotransposition; apurinic/apyrimidinic including read-through region interacts with its tar- endonucleases (APE)-like endonuclease at the N-terminus (15) get rDNA sequences of R1Bm, which plays important and reverse transcriptase at the central region. Retrotransposi- roles in initial process of TPRT in vivo. tion of this class is mainly studied for human L1 element using an assay to monitor retrotransposition in cultured human HeLa cells (16) and SART1 of the silkworm using the Autographa californica nuclear polyhedrosis virus (AcNPV) expression INTRODUCTION system (17). Although L1 and SART1 both have 30UTR and Non-long terminal repeat (non-LTR) retrotransposons, also poly (A) tail at their 30 end, they show different requirement called long interspersed nuclear elements (LINEs) or poly for the RNA sequence to initiate the reverse transcription. The (A) elements, are the most abundant family among mobile presence of 30 UTR is dispensable for L1 retrotransposition, *To whom correspondence should be addressed. Tel: +81 4 7136 3659; Fax: +81 4 7136 3660; Email: [email protected] ª The Author 2005. Published by Oxford University Press. All rights reserved. The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact [email protected] 1994 Nucleic Acids Research, 2005, Vol. 33, No. 6 Figure 1. Identification of a new subtype of the R1 element from the silkworm, Bombyx mori.(A) Schematic representation of 28S gene-specific LINEs. Shown in the middle is a diagram of the rDNA unit of Bombyx mori. The newly identified R1 clone (named R1Bmks) is integrated into the sequence 74 bp downstream of the R2 insertion site. Open reading frames (ORFs) are depicted by open boxes. The positions of non-synonymous mutations in the ORF1 and nucleotide insertions in the ORF2 (see B and C) are shown by white and black arrowheads, respectively. (B and C) Altered amino acid sequence of R1Bmks in the ORF2. Insertion of 3 nt within the RT domain results in alteration of 10 amino acids (indicated by bold line), compared with R1Bm (B). Addition of a single nucleotide in R1Bmks alters the amino acid sequences and made the length of ORF2 shorter by 12 amino acids, compared with R1Bm (C). The amino acids conserved between more than two elements are indicated by bold letters. Putative translational stop was indicated by asterisks. R1Bm clones are aligned with R1Dm (X51968; accession number) from D.melanogaster; R1Sc (L00945) from Sciara coprophila. but poly (A) tract seems essential (16). In addition, active L1 DNA extracted from Bombyx mori strain, Kinshu · Showa. elements possess the ability to transduce non-L1 DNA flank- The reaction mixture was denatured at 94C for 1 min, fol- ing their 30 ends to new genomic locations (3,18,19). In con- lowed by 30 cycles of 98C for 30 s, 60C for 30 s, and 72C trast, the recognition of 30UTR by SART1 proteins is crucial for 12 min. The PCR products were loaded on 0.6% agarose for the SART1 retrotransposition (17), and the loss of poly (A) gel, and electrophoresed. The DNA band in the calculated size tract resulted in a severe loss of the efficiency for the initiation was excised from the gel and purified by the QIAquick Gel of reverse transcription (20). Extraction Kit (Qiagen). The recovered product was digested R1Bm is a member of recently-branched subtype, and inser- with EcoRI and PstI, subcloned between the EcoRI and PstI ted specifically into the 28S rDNA of the silkworm (9,21). The sites of the pAcGHLTB plasmid (PharMingen). The resulting R1 insertion site is located 74 bp downstream of the R2 site plasmid, named R1WT-pAcGHLTB, contained the 64 bp 0 (Figure 1A) (22). R1Bm is flanked by specific 14 bp target site polyhedrin 5 UTR and the GST-X5-(His)6-X29 coding gene duplication (TSD), and lacks the poly (A) tract at its 30 end. fused in-frame with MSEEERE of the R1 ORF1, followed To understand the basal mechanisms of TPRT, it is of great by R1 ORF2/30UTR and the polyhedrin 30UTR. Point muta- interest to know how this poly (A)-less R1 initiates its reverse tions were introduced into R1WT-pAcGHLTB with primer transcription. In this study, we have newly cloned the R1 sets listed in Table 1 using QuickChangeTM Mutagenesis element from the silkworm genome, and firstly succeeded Kit (Stratagene). The mutation of each plasmid was confirmed in retrotransposing the R1 sequence into the 28S rDNA target by DNA sequencing. The D30UTR mutant was constructed by of the host cells with recombinant baculovirus, AcNPV. Using self-ligation of the DNA fragment amplified from R1WT- the in vivo retrotransposition system of R1, we studied the pAcGHLTB with the inverse PCR using 50-phosphorylated functional roles of 30UTR of R1 RNA and co-expressed 28S primers, R1 A4992 and pAcGHLTB-S3304. R1WT- rRNA downstream of R1 sequence. pAcGHLTB plasmids with various 30 tails were constructed as follows. First, 333 bp fragment of 30 junction between R1 and 28S rDNA was amplified by PCR with a primer set, R1 MATERIALS AND METHODS S4861 and 28S rDNA(+57) using the silkworm genomic DNA as a template and was directly cloned into pGEM-T vector Plasmid construction (Promega). Second, PCR reaction was conducted between R1 The R1 ORF1/ORF2/30UTR portion was directly amplified by S4861 and the various primers with PstI sites (Table 1), and the PCR with Pfu Turbo DNA polymerase (Stratagene) using resulting fragments were cloned into the NcoI and PstI sites of primers R1 S519, R1 A5136 (Table 1) and 5 ng of the genomic R1WT-pAcGHLTB. Nucleic Acids Research, 2005, Vol. 33, No. 6 1995 Table 1. List of primers Name Sequence (50!30) R1 S519 AAAAAGAATTCAGATGTCGGAGGAGGAGAGGGAGCTATTTTCCCCT R1 S4861 GTTTACCACGCGGACCTGGT R1 A4992 TCACCCACATTCTTCGTCGCCAGGCAGTCC
Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Identification of a Gene Coding for a Protein Possessing Shared Tumor Epitopes Capable of Inducing HLA-A24-Restricted Cytotoxic T Lymphocytes in Cancer Patients1
    [CANCER RESEARCH 59, 4056–4063, August 15, 1999] Identification of a Gene Coding for a Protein Possessing Shared Tumor Epitopes Capable of Inducing HLA-A24-restricted Cytotoxic T Lymphocytes in Cancer Patients1 Damu Yang, Masanobu Nakao, Shigeki Shichijo, Teruo Sasatomi, Hideo Takasu, Hajime Matsumoto, Kazunori Mori, Akihiro Hayashi, Hideaki Yamana, Kazuo Shirouzu, and Kyogo Itoh2 Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy [D. Y., M. N., K. I.], and Departments of Surgery [A. H., H. Y., K. S.], Immunology [S. S., T. S., H. T., H. M., K. I.], and Otolaryngology [K. M.], Kurume University School of Medicine, Kurume, 830-0011, Japan ABSTRACT we report a gene encoding epitopes that are capable of inducing CTLs in PBMCs of patients with SCCs and adenocarcinomas. Genes encoding tumor epitopes that are capable of inducing CTLs against adenocarcinomas and squamous cell carcinomas, two major hu- man cancers histologically observed in various organs, have rarely been MATERIALS AND METHODS identified. Here, we report a new gene from cDNA of esophageal cancer cells that encodes a shared tumor antigen recognized by HLA-A2402- Generation of HLA-A2402-restricted CTLs. HLA-A2402-restricted and restricted and tumor-specific CTLs. The sequence of this gene is almost tumor-specific CTLs were established from the PBMCs of an esophageal identical to that of the KIAA0156 gene, which has been registered in cancer patient (HLA-A2402/A2601) by the standard method of mixed lym- phocyte tumor cell culture,
    [Show full text]
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]
  • Product Datasheet SART1 Antibody NBP2-14836
    Product Datasheet SART1 Antibody NBP2-14836 Unit Size: 0.1 ml Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/NBP2-14836 Updated 10/25/2020 v.20.1 Earn rewards for product reviews and publications. Submit a publication at www.novusbio.com/publications Submit a review at www.novusbio.com/reviews/destination/NBP2-14836 Page 1 of 4 v.20.1 Updated 10/25/2020 NBP2-14836 SART1 Antibody Product Information Unit Size 0.1 ml Concentration 1.3 mg/ml Storage Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. Clonality Polyclonal Preservative 0.05% Sodium Azide Isotype IgG Purity Immunogen affinity purified Buffer PBS and 30% Glycerol Product Description Host Rabbit Gene ID 9092 Gene Symbol SART1 Species Human, Mouse Reactivity Notes Human and mouse. Immunogen displays the following percentage of sequence identity for non-tested species: rat (94%). Immunogen A synthetic peptide made to a internal portion of the human SART1 protein (between residues 100-200) [UniProt O43290] Product Application Details Applications Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin, ICC/IF (Negative) Recommended Dilutions Western Blot 1 ug/ml, Immunohistochemistry 1:200-1:500, Immunohistochemistry-Paraffin 1:200-1:500, ICC/IF (Negative) Application Notes This SART1 antibody is useful for IHC-paraffin embedded sections and Western blot. In Western blot a band is detected ~100 kDa in NIH-3T3 cell lysate. In IHC- P, staining was observed in the nuclei of mouse testes.
    [Show full text]
  • Use of Genome-Wide Expression Data to Mine the "Gray Zone" of GWA Studies Leads to Novel Candidate Obesity Genes
    Use of Genome-Wide Expression Data to Mine the "Gray Zone" of GWA Studies Leads to Novel Candidate Obesity Genes The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Naukkarinen, Jussi et al. “Use of Genome-Wide Expression Data to Mine the “Gray Zone” of GWA Studies Leads to Novel Candidate Obesity Genes.” PLoS Genet 6.6 (2010): e1000976. As Published http://dx.doi.org/10.1371/journal.pgen.1000976 Publisher Public Library of Science Version Final published version Citable link http://hdl.handle.net/1721.1/60388 Terms of Use Creative Commons Attribution Detailed Terms http://creativecommons.org/licenses/by/2.5/ Use of Genome-Wide Expression Data to Mine the ‘‘Gray Zone’’ of GWA Studies Leads to Novel Candidate Obesity Genes Jussi Naukkarinen1,2,3*, Ida Surakka1,2, Kirsi H. Pietila¨inen4,5, Aila Rissanen4, Veikko Salomaa6, Samuli Ripatti1,2, Hannele Yki-Ja¨rvinen7, Cornelia M. van Duijn8, H.-Erich Wichmann9,10,11, Jaakko Kaprio1,5,12, Marja-Riitta Taskinen13, Leena Peltonen1,2,3,14,15, ENGAGE Consortium" 1 FIMM, Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland, 2 Public Health Genomics Unit, National Institute for Health and Welfare, Helsinki, Finland, 3 Department of Medical Genetics, University of Helsinki, Helsinki, Finland, 4 Obesity Research Unit, Department of Psychiatry, Helsinki University Central Hospital, Helsinki, Finland, 5 Finnish Twin Cohort Study, Department of Public Health, University of Helsinki, Helsinki, Finland,
    [Show full text]
  • Discovery of a Molecular Glue That Enhances Uprmt to Restore
    bioRxiv preprint doi: https://doi.org/10.1101/2021.02.17.431525; this version posted February 17, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Title: Discovery of a molecular glue that enhances UPRmt to restore proteostasis via TRKA-GRB2-EVI1-CRLS1 axis Authors: Li-Feng-Rong Qi1, 2 †, Cheng Qian1, †, Shuai Liu1, 2†, Chao Peng3, 4, Mu Zhang1, Peng Yang1, Ping Wu3, 4, Ping Li1 and Xiaojun Xu1, 2 * † These authors share joint first authorship Running title: Ginsenoside Rg3 reverses Parkinson’s disease model by enhancing mitochondrial UPR Affiliations: 1 State Key Laboratory of Natural Medicines, China Pharmaceutical University, 210009, Nanjing, Jiangsu, China. 2 Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, 210009, Nanjing, Jiangsu, China. 3. National Facility for Protein Science in Shanghai, Zhangjiang Lab, Shanghai Advanced Research Institute, Chinese Academy of Science, Shanghai 201210, China 4. Shanghai Science Research Center, Chinese Academy of Sciences, Shanghai, 201204, China. Corresponding author: Ping Li, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 210009, Nanjing, Jiangsu, China. Email: [email protected], Xiaojun Xu, State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, 210009, Nanjing, Jiangsu, China. Telephone number: +86-2583271203, E-mail: [email protected]. bioRxiv preprint doi: https://doi.org/10.1101/2021.02.17.431525; this version posted February 17, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
    [Show full text]
  • Splicing Factors Sf3a2 and Prp31 Have Direct Roles in Mitotic Chromosome Segregation
    RESEARCH ARTICLE Splicing factors Sf3A2 and Prp31 have direct roles in mitotic chromosome segregation Claudia Pellacani1†, Elisabetta Bucciarelli1†, Fioranna Renda2‡, Daniel Hayward3, Antonella Palena1, Jack Chen3, Silvia Bonaccorsi2, James G Wakefield3, Maurizio Gatti1,2*, Maria Patrizia Somma1* 1Istituto di Biologia e Patologia Molecolari del CNR, Sapienza Universita` di Roma, Roma, Italy; 2Dipartimento di Biologia e Biotecnologie “C. Darwin”, Sapienza Universita` di Roma, Roma, Italy; 3Biosciences/Living Systems Institute, College of Life and Environmental Sciences, University of Exeter, Exeter, United Kingdom Abstract Several studies have shown that RNAi-mediated depletion of splicing factors (SFs) results in mitotic abnormalities. However, it is currently unclear whether these abnormalities reflect defective splicing of specific pre-mRNAs or a direct role of the SFs in mitosis. Here, we show that two highly conserved SFs, Sf3A2 and Prp31, are required for chromosome segregation in both Drosophila and human cells. Injections of anti-Sf3A2 and anti-Prp31 antibodies into Drosophila *For correspondence: embryos disrupt mitotic division within 1 min, arguing strongly against a splicing-related mitotic [email protected] (MG); function of these factors. We demonstrate that both SFs bind spindle microtubules (MTs) and the [email protected] Ndc80 complex, which in Sf3A2- and Prp31-depleted cells is not tightly associated with the (MPS) kinetochores; in HeLa cells the Ndc80/HEC1-SF interaction is restricted to the M phase.
    [Show full text]
  • Structural–Functional Interactions of NS1-BP Protein with the Splicing and Mrna Export Machineries for Viral and Host Gene Expression
    Structural–functional interactions of NS1-BP protein with the splicing and mRNA export machineries for viral and host gene expression Ke Zhanga, Guijun Shangb, Abhilash Padavannilb, Juan Wanga, Ramanavelan Sakthivela, Xiang Chenc,d, Min Kime, Matthew G. Thompsonf, Adolfo García-Sastreg,h,i, Kristen W. Lynchf, Zhijian J. Chenc,d, Yuh Min Chookb,1, and Beatriz M. A. Fontouraa,1 aDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390; bDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390; cDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390; dHoward Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390; eDepartment of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX 75390; fDepartment of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; gDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; hGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029; and iDivision of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029 Edited by Thomas E. Shenk, Princeton University, Princeton, NJ, and approved November 13, 2018 (received for review October 23, 2018) The influenza virulence factor NS1 protein interacts with the Viral mRNA splicing requires the cellular spliceosome. Most cellular NS1-BP protein to promote splicing and nuclear export of of cellular splicing occurs in the nucleoplasm, where splicing the viral M mRNAs. The viral M1 mRNA encodes the M1 matrix factors are recruited to nascent transcripts through interaction protein and is alternatively spliced into the M2 mRNA, which is with polymerase II (Pol II).
    [Show full text]
  • Supplementary Figure 1. Network Map Associated with Upregulated Canonical Pathways Shows Interferon Alpha As a Key Regulator
    Supplementary Figure 1. Network map associated with upregulated canonical pathways shows interferon alpha as a key regulator. IPA core analysis determined interferon-alpha as an upstream regulator in the significantly upregulated genes from RNAseq data from nasopharyngeal swabs of COVID-19 patients (GSE152075). Network map was generated in IPA, overlaid with the Coronavirus Replication Pathway. Supplementary Figure 2. Network map associated with Cell Cycle, Cellular Assembly and Organization, DNA Replication, Recombination, and Repair shows relationships among significant canonical pathways. Significant pathways were identified from pathway analysis of RNAseq from PBMCs of COVID-19 patients. Coronavirus Pathogenesis Pathway was also overlaid on the network map. The orange and blue colors in indicate predicted activation or predicted inhibition, respectively. Supplementary Figure 3. Significant biological processes affected in brochoalveolar lung fluid of severe COVID-19 patients. Network map was generated by IPA core analysis of differentially expressed genes for severe vs mild COVID-19 patients in bronchoalveolar lung fluid (BALF) from scRNA-seq profile of GSE145926. Orange color represents predicted activation. Red boxes highlight important cytokines involved. Supplementary Figure 4. 10X Genomics Human Immunology Panel filtered differentially expressed genes in each immune subset (NK cells, T cells, B cells, and Macrophages) of severe versus mild COVID-19 patients. Three genes (HLA-DQA2, IFIT1, and MX1) were found significantly and consistently differentially expressed. Gene expression is shown per the disease severity (mild, severe, recovered) is shown on the top row and expression across immune cell subsets are shown on the bottom row. Supplementary Figure 5. Network map shows interactions between differentially expressed genes in severe versus mild COVID-19 patients.
    [Show full text]
  • Engineered Type 1 Regulatory T Cells Designed for Clinical Use Kill Primary
    ARTICLE Acute Myeloid Leukemia Engineered type 1 regulatory T cells designed Ferrata Storti Foundation for clinical use kill primary pediatric acute myeloid leukemia cells Brandon Cieniewicz,1* Molly Javier Uyeda,1,2* Ping (Pauline) Chen,1 Ece Canan Sayitoglu,1 Jeffrey Mao-Hwa Liu,1 Grazia Andolfi,3 Katharine Greenthal,1 Alice Bertaina,1,4 Silvia Gregori,3 Rosa Bacchetta,1,4 Norman James Lacayo,1 Alma-Martina Cepika1,4# and Maria Grazia Roncarolo1,2,4# Haematologica 2021 Volume 106(10):2588-2597 1Department of Pediatrics, Division of Stem Cell Transplantation and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA; 2Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA; 3San Raffaele Telethon Institute for Gene Therapy, Milan, Italy and 4Center for Definitive and Curative Medicine, Stanford School of Medicine, Stanford, CA, USA *BC and MJU contributed equally as co-first authors #AMC and MGR contributed equally as co-senior authors ABSTRACT ype 1 regulatory (Tr1) T cells induced by enforced expression of interleukin-10 (LV-10) are being developed as a novel treatment for Tchemotherapy-resistant myeloid leukemias. In vivo, LV-10 cells do not cause graft-versus-host disease while mediating graft-versus-leukemia effect against adult acute myeloid leukemia (AML). Since pediatric AML (pAML) and adult AML are different on a genetic and epigenetic level, we investigate herein whether LV-10 cells also efficiently kill pAML cells. We show that the majority of primary pAML are killed by LV-10 cells, with different levels of sensitivity to killing. Transcriptionally, pAML sensitive to LV-10 killing expressed a myeloid maturation signature.
    [Show full text]
  • Cell Cycle Arrest and Apoptosis Induced by SART-1 Gene Transduction
    ANTICANCER RESEARCH 25: 1983-1990 (2005) Cell Cycle Arrest and Apoptosis Induced by SART-1 Gene Transduction MAMI HOSOKAWA1,2, RITSUKO KADOTA2, SHIGEKI SHICHIJO3, KYOGO ITOH3, IGOR DMITRIEV4, VICTOR KRASNYKH4, DAVID T. CURIEL4, YOICHI TAKUE1, HIRO WAKASUGI5, SHIGEMITSU TAKASHIMA2 and YUJI HEIKE1,2,5 1Blood and Stem Cell Transplantation Unit, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045; 2Department of Clinical Research, National Shikoku Cancer Center, 13-Horinouchi, Matsuyama, Ehime 790-0007; 3Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy and Department of Immunology, Kurume University School of Medicine, Asahi-machi 67, Kurume, Fukuoka 830-0011, Japan; 4Gene Therapy Center, University of Alabama at Birmingham, BMR2 502, 901 19th Street South, Birmingham, AL 35294-2172, U.S.A.; 5Pharmacology Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan Abstract. The biological function of the SART-1 gene product become available and researchers seeking tumor antigens is demonstrated and its potential as a target for cancer gene have reported that some identified sequences are active in therapy is discussed. Materials and Methods: The SART-1 gene vivo. SART-1 is ubiquitously expressed in various cancers, was transduced by a recombinant adenovirus vector and its including breast, esophagus, lung and uterine cancers (4-10). expression was promoted by a CMV promoter. Results: The SART-1 encodes both the SART-1259 antigen, expressed in transduction efficiency by recombinant adenoviruses in A549 the cytosol of epithelial cancers and the SART-1800 antigen, and MCF-7 cells was determined using a vector expressing expressed in the nuclei of most proliferating cells (11-15).
    [Show full text]